Aclaris Therapeutics ACRS
NASDAQ ACRS
$4.39 -0.02 (-0.45%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aclaris Therapeutics (ACRS) Change in Intangibles (2025)

Updated

Aclaris Therapeutics' Change in Intangibles was $833,000 in Q1 2025.

Analysis

Aclaris Therapeutics (ACRS) Change in Intangibles (2025) Analysis & Trends

For FY2024, Change in Intangibles at Aclaris Therapeutics came in at $35.81 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Intangibless (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.28 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -437.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.34 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Aclaris Therapeutics 613.83 Mn 613.83 Mn 1.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 833,000.00
API Access

Aclaris Therapeutics Change in Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-intangibles&ticker=ACRS&period=max&api_key=YOUR_API_KEY